Related Experiment Video

Updated: Aug 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Diabetic dyslipidaemia: effective management reduces cardiovascular risk

Lawrence A Leiter1

  • 1Departments of Medicine and Nutritional Sciences, University of Toronto, St Michael's Hospital, 61 Queen Street East #6121Q, Toronto, Ontario, Canada M5C 2T2. leiter@smh.utoronto.on.ca

Atherosclerosis. Supplements
|April 13, 2005
PubMed

Insights

Diabetic patients face high coronary heart disease (CHD) risks. Aggressive statin therapy significantly reduces vascular events by 22-24% in these high-risk individuals.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetes significantly increases coronary heart disease (CHD) risk, even without prior myocardial infarction (MI).
  • Patients with diabetes have a risk of fatal or nonfatal MI comparable to non-diabetic patients with a history of MI.
  • Aggressive treatment of cardiovascular risk factors is recommended for diabetic patients, similar to non-diabetic patients with established CHD.

Purpose of the Study:

  • To evaluate the effectiveness of statin therapy in reducing vascular events in patients with diabetes.
  • To review current guidelines and evidence supporting aggressive lipid-lowering interventions for diabetic patients.
  • To address the gap between recommended and actual treatment of lipid-lowering therapies in diabetes management.

Main Methods:

  • Analysis of results from the Collaborative Atorvastatin Diabetes Study (CARDS).
  • Meta-analysis of primary and secondary intervention trials involving statin use in high-risk patients, including those with diabetes.
  • Review of current National Cholesterol Education Program (NCEP) guidelines.

Main Results:

  • Statin treatment demonstrated a uniform relative risk reduction across various high-risk patient groups, including those with diabetes but without established CHD.
  • A significant 22-24% reduction in the risk of future vascular events was observed in diabetic patients treated with statins.
  • Current guidelines recommend aggressive, early intervention for very-high-risk patients, such as those with diabetes and cardiovascular disease (CVD), aiming for LDL-C below 70 mg/dL.

Conclusions:

  • Despite evidence, many diabetic patients remain undertreated for lipid-lowering.
  • More effective statins and improved patient compliance are crucial to bridge the treatment gap.
  • Aggressive lipid-lowering interventions are vital for managing cardiovascular risk in patients with diabetes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...